
Sealero Pharma Private Limited
About Sealero Pharma Private Limited
Data last updated:
Sealero Pharma Private Limited is a private limited company based in Jhansi, Uttar Pradesh, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 27 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2019PTC123888.
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Beena Tiwari and Rajiv Kumar Dwivedi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 491 New Friends Colony Thapak Bagh Talaiya Bahar Datiya Gate, Jhansi, Uttar Pradesh, India – 284002.
As per the financials filed for FY 2024, the company reported a revenue of ₹13,500, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹3,967 (net margin -29.4%) and EBITDA of -₹170 (EBITDA margin -1.3%). Revenue has declined at a compounded annual rate (CAGR) of 60% over three years.
Company details
Contact details
Sealero Pharma Private Limited's registered office is in Jhansi, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address491 New Friends Colony Thapak Bagh Talaiya Bahar Datiya Gate, Jhansi, Uttar Pradesh, India – 284002
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Sealero Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sealero Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sealero Pharma Private Limited, buy the company report.
Financials of Sealero Pharma Private Limited
FY 2025 filings availableSealero Pharma Private Limited reported revenue of ₹13,500 (down 98% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 60% over three years, including a 98% fall in the latest year. EBITDA fell 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹170 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3,967 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.3% | ||||
| Net Profit Margin | -29.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sealero Pharma Private Limited, buy the company report.
Board of directors of Sealero Pharma Private Limited
Sealero Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Beena Tiwari | Director | 27 Nov 2019 | 6 Years 11 Months | Current |
| Rajiv Kumar Dwivedi | Director | 27 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Sealero Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Next Gen Dna Lab Private Limited | ₹13,900 (FY 2025) | -86.0% | Bangalore, Karnataka, India | |||
| Mehar International Marketing Private Limited | ₹13,877 (FY 2025) | -98.0% | Mohali, Punjab, India | |||
| Gratila Healthcare Private Limited | ₹13,803 (FY 2025) | -99.0% | Pune, Maharashtra, India | |||
| Buboo's Foundation | ₹13,800 (FY 2025) | -78.0% | West Bengal, India | |||
| Maagan Healthcare Private Limited | ₹13,525 (FY 2022) | -94.0% | New Delhi, Delhi, India | |||
| Sealero Pharma Private Limitedthis company | ₹13,500 (FY 2024) | -₹3,967 | -29.4% | -98.0% | Jhansi, Uttar Pradesh, India | |
| Balu Health Care Private Limited | ₹13,490 (FY 2019) | Tadepalligudem, Andhra Pradesh, India | ||||
| Mind Master Counsellors Private Limited | ₹13,281 (FY 2018) | -97.0% | Ahmednagar, Maharashtra, India | |||
| Sri Krishna Sai Diagnostic and Research Institute Private Limited | ₹13,231 (FY 2024) | -69.0% | Hyderabad, Telangana, India | |||
| Rssparkle Life Private Limited | ₹13,180 (FY 2020) | 6.0% | Gonda, Uttar Pradesh, India | |||
| Margsathi Healthcare Network Private Limited | ₹13,100 (FY 2025) | Darbhanga, Bihar, India |
To see the full peer comparison of Sealero Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sealero Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sealero Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sealero Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sealero Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Beena Tiwari was appointed as Director on 27 Nov 2019.
Frequently asked questions
Sealero Pharma is an active private limited company based in Jhansi, Uttar Pradesh, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 27 November 2019 (7+ years old) and is registered under CIN U24304UP2019PTC123888.
Sealero Pharma has 2 current directors:
- Beena Tiwari - Director
- Rajiv Kumar Dwivedi - Director
The latest financial statements of Sealero Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Sealero Pharma is U24304UP2019PTC123888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sealero Pharma was incorporated on 27 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Sealero Pharma by revenue are Next Gen Dna Lab Private Limited, Mehar International Marketing Private Limited, Gratila Healthcare Private Limited, Buboo's Foundation, Maagan Healthcare Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Beena Tiwari was appointed as Director on 27 Nov 2019. Rajiv Kumar Dwivedi was appointed as Director on 27 Nov 2019.
The registered office of Sealero Pharma is at 491 New Friends Colony Thapak Bagh Talaiya Bahar Datiya Gate, Jhansi, Uttar Pradesh, India – 284002.
Sealero Pharma operates in the food and beverages industry, in the manufacturing segment.
Sealero Pharma can be reached at its registered office: 491 New Friends Colony Thapak Bagh Talaiya Bahar Datiya Gate, Jhansi, Uttar Pradesh, India – 284002.
Sealero Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.

